Abstract Body

Background: Chronic immune activation may be in part attributable to translocation of microbial TLR ligands from the GI tract into the systemic circulation, but may involve direct effects of viral proteins and nucleic acids and activation of bystander host immune cells. We investigated whether novel HIV-derived miRNAs can directly induce macrophage proinflammatory cytokine release via non-canonical pathway. Methodology: HIV miRNAs including vmiRNA-TAR and two novel HIV miRNA designated as vmiR88 and vmiR99 (determined by UNAfold RNA folding software, from R/U5 and U5 regions of HIV LTR, each with requisite short hairpin structure and highly conserved sequence vs. several clinical HIV isolates) were synthesized by IDT (Coralville, IA). Human macrophages U937 and HIV+U1 cell lines (differentiated with PMA), and human alveolar macrophages (AM) from consenting healthy or asymptomatic HIV+ volunteers (hospital IRB-approved bronchoscopy protocol) were isolated by adherence. For select experiments, healthy AM were infected in vitro by HIV-Bal isolate x 2 weeks. For select experiments, RNAi targeted TLR8 gene silencing performed by Amaxa. HIV miRNA detected by ultrasensitive qRT-PCR on cell lysates, and exosomal fraction of macrophages cultured supernatants and archived sera from healthy and asymptomatic HIV+ persons. TNF release in cultured supernatants determined by ELISA. Results: Exosomal fraction of sera from asymptomatic HIV+ persons with CD4+ T-lymphocyte counts <200 cells/mm3, undetectable viral load, prescribed cART demonstrated abundant HIV vmiR-TAR in 92% of persons, in addition to both novel vmiR88 and vmiR99 each in 54% of persons, often exceeding levels of vmiR-TAR. In addition, vmiRNA-TAR, vmiR88 and vmiR99 were detected in cell lysates, released by HIV-infected macrophages upon PMA stimulation, released by AM following in vitro HIV infection, and associated with exosomal fractions. Exogenous vmiR88 and vmiR99 (but not vmiR-TAR) directly stimulated TNF release by human macrophages, dependent on macrophage TLR8 and vmiRNA GU-content. Finally, HIV vmiR-mediated TNF release was neutralized by specific complimentary antagomirs duplexing with HIV vmiRNAs. Conclusions: Novel HIV-derived vmiRNAs stimulate macrophage TNF release through non-canonical pathway and may contribute to chronic immune activation in HIV-infected persons. HIV miRNAs may represent novel therapeutic targets to limit HIV disease pathogenesis.